应当摒弃“糖喂养癌症”的观点：糖喂养每一个细胞（和微生物），所以癌症患者不必害怕糖。
原始表述
السكر يا بابا غذا كل حاجه البكتيريا بتاكل سكر
按来源为原话. 译文由本项目提供；以阿拉伯语原文为准。
译文
应当摒弃“糖喂养癌症”的观点：糖喂养每一个细胞（和微生物），所以癌症患者不必害怕糖。
出处
- 来源状态
- 视频转录文本（本人原话）
- 归属
- Elawady (machine transcript)
- 视频
- السرطان ١ (打开来源)
- 发布日期
- 2025年1月26日
- 时间戳
- 0:22:03 (在原视频 YouTube 自动字幕轨中的位置；可确认该内容出现的位置，但不能确认说话人是谁)
- 归属的不确定性
- Archive transcript (YouTube CC or AI-generated); no timestamps; spelling errors of the machine transcript are kept verbatim; wording may deviate from the spoken words.
- 涉及人群
Cancer patients
- Elawady 设定的地域限制
none found
科学评估
不明确 / 证据不足 – 现有数据无法支持任何方向的评估。
证据确定性: 低 – 进一步研究很可能大幅改变该评估。
1. 说法是什么？
Sugar does not specifically feed cancer; no need to restrict it in cancer.
2. 哪些内容可证实是正确的？
All cells use glucose and blood glucose is regulated; the slogan 'sugar feeds cancer' oversimplifies, and restricting all carbohydrate is not an established cancer treatment.
3. 哪些内容是错误或夸大的？
High sugar intake is associated with weight gain (moderate-quality evidence) and, with low-quality evidence, with some cancers (e.g., fructose and pancreatic cancer) (I-CAN-07); excess body weight causes about 7.6% of US cancers (I-CAN-02). Elawady's broader pro-sugar positions are reviewed by the sugar_soda team.
4. 哪些内容仍不明确？
Effect of sugar intake on outcomes in people who already have cancer.
5. 哪些研究支持该说法？
Partly: the slogan 'sugar feeds cancer' oversimplifies physiology, and no direct evidence was reviewed that dietary sugar speeds tumour growth in patients; the umbrella review rates evidence on sugar and cancer as low quality (I-CAN-07).
6. 哪些研究与该说法相矛盾？
7. 对德国和欧洲而言情况如何？
Not region-specific; the same physiology and evidence apply.
8. 关于埃及的已知情况是什么？
Not region-specific; the same physiology and evidence apply.
9. 合理的实际结论是什么？
癌症患者的饮食应与肿瘤/营养团队一起进行个体化调整（例如考虑糖尿病、体重下降、恶病质等情况）。
评估详情
- 证据确定性的依据
No direct evidence reviewed on dietary sugar and tumour progression in patients; observational data on sugar and cancer incidence are low quality; indirect harms via body weight.
- 来源质量
Machine transcript.
- 地区可推广性
High.
- 说法的地域范围
- 普遍性（生物学/医学）
- 最近审核
- 2026年10月26日 初步
科学证据详解
研究不足 – 研究太少，无法判断该说法是对是错。
研究问题: In people with cancer, does dietary sugar intake affect cancer outcomes, and is restricting sugar unnecessary?
研究问题详解 (PECO)
- 人群
- People with cancer (and general population for incidence)
- 干预或暴露
- Dietary sugar / sugary drinks / refined carbohydrates
- 对照
- Lower intake; carbohydrate-restricted diets
- 地域范围
- universal biology
- 结局指标
- Survival / recurrence
- Cancer incidence
- Body weight
研究结果按作者报告呈现。我们的评估见下文。
哪些证据支持该说法？
Ketogenic diet trials in cancer: little proven benefit
RCT meta-analysis: ketogenic (sugar-restricted) diets did not clearly improve cancer-related outcomes.
- 实际结果
- Only glucose fell; no significant change in IGF-1, weight, QoL
- 方法学质量
- moderate
- 相关性
- indirect: no proof that cutting sugar helps patients
- 局限
- Small, short trials.
US cancer doctors' guideline: exercise helps, diet evidence weak
ASCO: evidence for specific diets during treatment very limited.
- 实际结果
- Guideline statement
- 方法学质量
- high
- 相关性
- indirect
- 局限
- Evidence base thin.
哪些证据不支持该说法？
Sugary drinks after breast cancer linked to higher death risk
Post-diagnosis sugary drinks in 8,863 breast cancer survivors (NHS/NHSII).
- 实际结果
- BC-specific mortality HR 1.35 (1.12-1.62) for >3 servings/week; dose-response
- 方法学质量
- moderate (large prospective cohort, adjusted for adiposity)
- 相关性
- direct (patients)
- 局限
- Observational.
Diet after bowel cancer and survival
Post-diagnosis diet in colorectal cancer survivors.
- 实际结果
- Refined grains RR 1.55 (1.03-2.33) for all-cause mortality; authors advise avoiding SSB
- 方法学质量
- moderate (meta-analysis of cohorts)
- 相关性
- direct (patients)
- 局限
- Observational; SSB estimate not in abstract.
Sugary drinks and cancer risk in France
Sugary drinks and cancer incidence (NutriNet-Sante).
- 实际结果
- sHR 1.18 per 100 mL/day (1.10-1.27)
- 方法学质量
- moderate
- 相关性
- indirect (incidence)
- 局限
- Short follow-up.
总体证据说明了什么？
基于上述研究的编辑评估——其本身并非研究结果。
哪种观点有更好的证据支持？
Both extremes are unsupported: dietary sugar does not selectively 'feed' tumours in a way shown to matter clinically, and no sugar-restricted diet has proven cancer benefit; but high intake of sugary drinks and refined carbohydrates is associated with higher cancer risk and with worse survival after breast and colorectal cancer.
为什么有些研究权重更大
Post-diagnosis cohort data (I-CAN-127, I-CAN-111) are most direct; RCTs of carbohydrate restriction (I-CAN-104) are small; incidence data are indirect.
因果关系是否已确立？ 有可能，尚未确立 Associations are plausible via weight and insulin, but confounding is likely and RCTs are lacking.
仍存在的不确定性
Effect of sugar intake on progression in specific cancers.
合理的结论
The slogan 'sugar feeds cancer' is too simple, but 'no need to watch sugar' is not supported either.
为什么研究结果看起来互相矛盾？
Not a true conflict: RCTs test strict carbohydrate restriction over weeks, cohorts test habitual sugary drinks and refined grains over years.
这是否取决于国家？
- 一般生物学效应
- Universal human biology; applies in Egypt, Germany and elsewhere.
- 饮食习惯
- Not decisive for this claim.
- 食品原产地
- Not relevant.
- 污染物
- Not relevant.
- 本国生产条件
- Not relevant.
- 法律规则
- Not relevant.
- 实际监测数据
- Not applicable.
足以改变结论的地区差异没有可靠数据支持。
统计复核
- CI log-symmetry; dose-response – All symmetric; p-trend .001. 已重新计算
- CI log-symmetry; multiplicity – Symmetric; refined-grain lower bound 1.03 -> fragile; many exposures tested. 已重新计算
- CI log-symmetry – Symmetric. 已重新计算
总体证据的确定性（GRADE，简化版）
- 主要结局
- Sugar intake and outcomes in people with cancer
- 起始等级
- 低（观察性研究）
- 降级理由
- risk of bias (confounding)
- indirectness (incidence data, refined grains vs sugar)
- imprecision
- 结果
- 低
由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。
已核查的临床指南和官方声明
- ASCO: Exercise, Diet, and Weight Management During Cancer Treatment (PMID 35576506) (2022) · 原始文献
Exercise recommended during curative treatment; neutropenic diets not recommended; evidence for other dietary and weight-loss interventions during treatment very limited (abstract). - WCRF/AICR: Our Cancer Prevention Recommendations (2018 (accessed 2026)) · 原始文献
Ten recommendations including eat wholegrains, vegetables, fruit and beans; limit fast foods, red and processed meat, sugar-sweetened drinks and alcohol; do not use supplements for cancer prevention; follow the recommendations after a cancer diagnosis if you can.
检索策略
本次审查的文献检索记录（检索式采用原数据库语法）。
| 数据库 | 日期 | 检索式 | 检索目标 | 命中数 | 纳入数 |
|---|---|---|---|---|---|
| Europe PMC | 2026年10月26日 | (sugar OR "added sugar" OR "sugar-sweetened" OR fructose OR "glycemic load") AND ("cancer survivors" OR "cancer recurrence" OR "cancer-specific mortality" OR "after diagnosis") AND (cohort OR prospective OR "meta-analysis") | 双向 | 6473 | |
| Europe PMC | 2026年10月26日 | ("sugary drinks" OR "sugar-sweetened beverages" OR "sugary drink") AND (cancer) AND (risk OR incidence) AND (TITLE:cancer) AND (PUB_TYPE:"Meta-Analysis" OR TITLE:"cohort" OR TITLE:"prospective") | 反对性证据 | 197 | |
| Europe PMC | 2026年10月26日 | TITLE:"Sugary drink consumption and risk of cancer" | 反对性证据 | 1 | |
| Europe PMC | 2026年10月26日 | (Tayebat OR Tayibat OR Elawady OR "El-Awady diet" OR "Al-Awady") | 双向 | 377 | |
| PubMed | 2026年10月26日 | (sugar[ti] OR carbohydrate[ti] OR "glycemic"[ti]) AND (cancer survivors[tiab] OR "after diagnosis"[tiab]) AND (survival[tiab] OR recurrence[tiab]) | 支持性证据 | 11 |
待解决的问题
RCTs of sugar reduction after diagnosis.
核查深度如何？
9 项相关研究：0 项核查了全文（其中 0 项进行了结构化偏倚风险评估），9 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。
最近一次科学审核: 2026年10月26日
评定结论的变更历史
通俗解释
Diaa 医生说，“糖喂养癌症”的观点是错误的，因为糖喂养所有细胞。这个口号确实过于简单。但吃大量的糖会促使体重增加，而超重会增加多种癌症的风险。癌症患者应该吃多少糖，因人而异，应与照护团队一起决定。
与该说法相关的研究
支持该说法的研究 (0)
该组中没有研究。
与该说法相矛盾或限制该说法的研究 (2)
-
Sugary drinks and cancer risk in France
Chazelas E et al.. BMJ 2019 · PMID 31292122 · DOI 10.1136/bmj.l2408队列研究独立交叉核查已核查摘要Each extra 100 mL of sugary drinks per day was linked to 18% higher cancer risk.
Sugary drinks associated with higher cancer incidence
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Sugary drinks and cancer.
- 研究是如何开展的？
Prospective cohort.
- 研究了多少人、动物或样本？
101,257 adults.
- 实际发现了什么？
Higher risk with sugary drinks.
- 观察到的效应有多大？
sHR 1.18 per 100 mL/d.
- 研究结果对日常生活意味着什么？
Limiting sugary drinks is sensible.
- 该研究有哪些局限？
Observational; short follow-up.
- 它对 Elawady 的具体说法说明了什么？
Contradicts 'no need to fear sugar' for prevention.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Effects in patients already diagnosed.
-
Sugary drinks after breast cancer linked to higher death risk
Farvid MS et al.. Cancer 2021 · PMID 33945630 · DOI 10.1002/cncr.33461队列研究独立交叉核查已核查摘要★ 关键研究Women who drank sugary drinks after a breast cancer diagnosis had a 31-35% higher risk of dying from breast cancer.
Post-diagnosis SSB linked to 31-35% higher breast cancer mortality
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
SSB after breast cancer and death.
- 研究是如何开展的？
Prospective cohort.
- 研究了多少人、动物或样本？
8,863 survivors.
- 实际发现了什么？
Higher mortality with SSB; not with diet drinks.
- 观察到的效应有多大？
HR 1.35 (>3 servings/week).
- 研究结果对日常生活意味着什么？
Limiting sugary drinks after cancer is sensible.
- 该研究有哪些局限？
Observational.
- 它对 Elawady 的具体说法说明了什么？
Contradicts the claim.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Cause and effect.
该组中没有被标记为关键研究的研究。
结果不一或不明确的研究 (7)
-
High sugar intake is linked to many health problems, weakly to some cancers
Huang Y et al.. BMJ 2023 · PMID 37019448 · DOI 10.1136/bmj-2022-071609系统综述独立交叉核查已核查摘要Evidence for weight gain is moderate; links with cancers are mostly low quality.
Low-quality associations with some cancers; weight gain
该研究是否支持这一具体说法？ 不明确 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Review sugar-health evidence.
- 研究是如何开展的？
Umbrella review.
- 研究了多少人、动物或样本？
73 meta-analyses.
- 实际发现了什么？
Mostly harmful associations.
- 观察到的效应有多大？
Fructose +22% pancreatic cancer per 25 g/d (low quality).
- 研究结果对日常生活意味着什么？
Limit added sugar.
- 该研究有哪些局限？
Observational.
- 它对 Elawady 的具体说法说明了什么？
Does not show sugar 'feeds' tumours.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Effects in cancer patients.
-
Four in ten cancers in the USA are linked to avoidable risk factors, led by smoking
Islami F et al.. CA Cancer J Clin 2024 · PMID 38990124 · DOI 10.3322/caac.21858风险评估独立交叉核查已核查摘要★ 关键研究Smoking accounted for 19% of cancers and 29% of cancer deaths; excess weight and alcohol followed.
Excess body weight is a cancer risk
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Estimate preventable cancers.
- 研究是如何开展的？
PAF analysis.
- 研究了多少人、动物或样本？
US 2019.
- 实际发现了什么？
40% of cases attributable.
- 观察到的效应有多大？
Smoking 19.3%/28.5%.
- 研究结果对日常生活意味着什么？
Not smoking, healthy weight, less alcohol and a diet with fibre, fruit and vegetables lower risk.
- 该研究有哪些局限？
Model assumptions.
- 它对 Elawady 的具体说法说明了什么？
Diet matters but is not the main cause.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
Individual cause.
-
Diet after bowel cancer and survival
Chen QY et al.. J Natl Cancer Inst 2025 · PMID 40317134 · DOI 10.1093/jnci/djaf098Meta分析独立交叉核查已核查摘要★ 关键研究Bowel cancer survivors who ate more whole grains, milk and calcium lived longer; more refined grains and high-fat dairy was linked to shorter survival.
Refined grains associated with higher mortality after CRC; authors advise avoiding SSB
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Diet after CRC diagnosis and death.
- 研究是如何开展的？
Meta-analysis of cohorts.
- 研究了多少人、动物或样本？
CRC survivors.
- 实际发现了什么？
Whole grains, milk, calcium protective; refined grains harmful.
- 观察到的效应有多大？
e.g. refined grains RR 1.55; milk RR 0.82.
- 研究结果对日常生活意味着什么？
What patients eat may matter.
- 该研究有哪些局限？
Observational.
- 它对 Elawady 的具体说法说明了什么？
Does not support ignoring sugar or banning dairy.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Cause and effect.
-
Ketogenic diets in cancer patients: some metabolic benefits
Zhang M et al.. Front Nutr 2025 · PMID 40756563 · DOI 10.3389/fnut.2025.1535921Meta分析独立交叉核查已核查摘要Ketogenic diets lowered body fat, insulin and glucose and improved some symptoms; survival was not shown to improve.
Carbohydrate restriction lowers glucose/insulin; no evidence of tumour control
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 低 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Effect of ketogenic diets in cancer patients.
- 研究是如何开展的？
Systematic review and meta-analysis.
- 研究了多少人、动物或样本？
Cancer patients in controlled studies.
- 实际发现了什么？
Better metabolic and some quality-of-life measures.
- 观察到的效应有多大？
Not quantified in abstract.
- 研究结果对日常生活意味着什么？
A diet can affect how patients feel and some blood values.
- 该研究有哪些局限？
Surrogate outcomes; small studies.
- 它对 Elawady 的具体说法说明了什么？
Does not show that a diet treats cancer.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
That any diet cures or controls cancer.
-
Ketogenic diet trials in cancer: little proven benefit
Salido-Bueno B et al.. Nutr Bull 2024 · PMID 38923748 · DOI 10.1111/nbu.12693Meta分析独立交叉核查已核查摘要In 7 small randomised trials, a ketogenic diet lowered blood glucose but did not clearly improve other cancer-related measures.
Carbohydrate restriction lowers glucose but no shown benefit on cancer outcomes
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Assess ketogenic diet effects in cancer RCTs.
- 研究是如何开展的？
Meta-analysis of RCTs.
- 研究了多少人、动物或样本？
8 RCTs of 4-16 weeks.
- 实际发现了什么？
Only glucose fell.
- 观察到的效应有多大？
Not quantified in abstract.
- 研究结果对日常生活意味着什么？
No diet has been shown to treat cancer.
- 该研究有哪些局限？
Small, short trials.
- 它对 Elawady 的具体说法说明了什么？
Contradicts diet-as-treatment claims.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
Long-term effects.
-
US cancer doctors' guideline: exercise helps, diet evidence weak
Ligibel JA et al.. J Clin Oncol 2022 · PMID 35576506 · DOI 10.1200/JCO.22.00687指南 / 立场声明独立交叉核查已核查摘要★ 关键研究ASCO found that exercise helps during cancer treatment but that evidence for specific diets is very limited.
No diet (including sugar restriction) proven during treatment
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guide exercise, diet and weight during cancer treatment.
- 研究是如何开展的？
Systematic review plus expert panel.
- 研究了多少人、动物或样本？
52 reviews and 23 RCTs.
- 实际发现了什么？
Exercise helps; no diet shown to control cancer.
- 观察到的效应有多大？
Not applicable.
- 研究结果对日常生活意味着什么？
Diet can support, not replace, treatment.
- 该研究有哪些局限？
Few diet trials.
- 它对 Elawady 的具体说法说明了什么？
Contradicts diet as cancer cure.
- 研究结果是否适用于德国和欧洲？
High.
- 从该研究中明确不能得出什么结论？
Absence of effect for all diets.
-
Ketogenic diet added to chemotherapy for pancreatic cancer: early trial
Jameson GS et al.. Cancer 2026 · PMID 41817106 · DOI 10.1002/cncr.70343随机对照试验独立交叉核查已核查摘要★ 关键研究In 32 patients, adding a supervised ketogenic diet to chemotherapy showed a trend toward longer survival that was not statistically confirmed.
Carbohydrate restriction during chemotherapy: unconfirmed trend
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Test a ketogenic diet added to chemotherapy.
- 研究是如何开展的？
Randomised phase II trial.
- 研究了多少人、动物或样本？
32 patients.
- 实际发现了什么？
Trends toward longer PFS/OS.
- 观察到的效应有多大？
PFS HR 0.53 (0.21-1.37).
- 研究结果对日常生活意味着什么？
Diet research in cancer is about adding to treatment, not replacing it.
- 该研究有哪些局限？
Small; uncertain; COI.
- 它对 Elawady 的具体说法说明了什么？
Does not support diet instead of treatment.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
Any proven survival benefit.
该组中没有被标记为关键研究的研究。
地区背景
德国 / 欧盟
Not region-specific; the same physiology and evidence apply.
埃及
Not region-specific; the same physiology and evidence apply.
在我的国家适用什么？
一般科学评估
不明确 / 证据不足 “糖喂养癌症”这一口号过于简单化，但大量摄入糖并非无害。
以下食品安全领域与该说法相关：
- 添加剂与加工
蜂蜜、糖、甜食
选择一个国家，查看针对该国已核查的信息。
局限：法律规则描述的是允许什么，而不是每一种食品实际含有什么。检测数据来自样本，只有结合其方法细节才有意义。
参考文献
- Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort.. Chazelas E et al.. BMJ 2019 · PMID 31292122 · DOI 10.1136/bmj.l2408
- Consumption of sugar-sweetened and artificially sweetened beverages and breast cancer survival.. Farvid MS et al.. Cancer 2021 · PMID 33945630 · DOI 10.1002/cncr.33461
- Dietary sugar consumption and health: umbrella review.. Huang Y et al.. BMJ 2023 · PMID 37019448 · DOI 10.1136/bmj-2022-071609
- Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019.. Islami F et al.. CA Cancer J Clin 2024 · PMID 38990124 · DOI 10.3322/caac.21858
- Postdiagnosis dietary and lifestyle factors and mortality outcomes among colorectal cancer patients: a meta-analysis.. Chen QY et al.. J Natl Cancer Inst 2025 · PMID 40317134 · DOI 10.1093/jnci/djaf098
- Impact of ketogenic diets on cancer patient outcomes: a systematic review and meta-analysis.. Zhang M et al.. Front Nutr 2025 · PMID 40756563 · DOI 10.3389/fnut.2025.1535921
- Effects of ketogenic diets on cancer-related variables: A systematic review and meta-analysis of randomised controlled trials.. Salido-Bueno B et al.. Nutr Bull 2024 · PMID 38923748 · DOI 10.1111/nbu.12693
- Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline.. Ligibel JA et al.. J Clin Oncol 2022 · PMID 35576506 · DOI 10.1200/JCO.22.00687
- A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer.. Jameson GS et al.. Cancer 2026 · PMID 41817106 · DOI 10.1002/cncr.70343